Georgios Tsakonas

All papers authored by Georgios Tsakonas

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 I. Zerdes

, C. Kamali

, A. Koulouris

, M. Elsayed, J. Schnorbach

, P. Christopoulos

, G. Tsakonas

Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases

Upload

This paper was not found in any repository, but could be made available legally by the author.

Georgios Tsakonas

, Simon Ekman, Andreas Koulouris

, Helen Adderley, Christoph Jakob Ackermann, Raffaele Califano

Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis

Upload

This paper is made freely available by the publisher.

2022 Georgios Tsakonas

, Andreas Koulouris, Dominika Kazmierczak, Johan Botling, Cristian Ortiz-Villalon, Helena Nord, Magnus Lindskog

, Martin Sandelin, Patrick Micke

, Per Hydbring, Simon Ekman

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Download from doi.org

Zeinab Kosibaty

, Odd Terje Brustugun

, Inger Johanne Zwicky Eide, Georgios Tsakonas

, Oscar Grundberg, Luigi De Petris, Marc McGowan, Per Hydbring, Simon Ekman

Download from doi.org

2021 Georgios Tsakonas

, Alfonso Martín-Bernabé

, Konstantinos Rounis

, Pablo Moreno-Ruiz

, Johan Botling, Luigi De Petris, Antti Ylipää, Artur Mezheyeuski

, Patrick Micke

, Arne Östman, Simon Ekman

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC

Download from doi.org

Konstantinos Rounis

, Marcus Skribek

, Dimitrios Makrakis, Luigi De Petris, Sofia Agelaki, Simon Ekman, Georgios Tsakonas

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Download from doi.org

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, Odd Terje Brustugun, Kjersti Hornslien, Tesfaye Madebo, Seppo Wang Langer, Tine Schytte, Jan Nyman, Signe Risum, Georgios Tsakonas

, Jens Engleson, Tarje Onsøien Halvorsen

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

Upload

Distributing this paper is prohibited by the publisher

Vitali Grozman, Eva Onjukka, Peter Wersäll, Ingmar Lax, Georgios Tsakonas

, Sven Nyren, Rolf Lewensohn, Karin Lindberg

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc – effects and side effects

Upload

Marcus Skribek

, Konstantinos Rounis, Soren Afshar

, Oscar Grundberg, Signe Friesland, Georgios Tsakonas

, Simon Ekman

, Luigi De Petris

Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors

Upload

2020 Marcus Skribek

, Konstantinos Rounis, Dimitrios Makrakis

, Sofia Agelaki, Dimitris Mavroudis, Luigi De Petris, Simon Ekman, Georgios Tsakonas

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting

Download from doi.org

Georgios Tsakonas

, Lena Specht, Claus Andrup Kristensen, Maria Herlestam Calero Moreno, Hedda Haugen Cange, Karin Soderstrom

, Signe Friesland

Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)

Download from doi.org

Katerina Chatzidionysiou

, Matina Liapi, Georgios Tsakonas

, Iva Gunnarsson, Anca Catrina

Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?

Download from link.springer.com

Georgios Tsakonas

, Caroline Kamali

, Luigi De Petris, Signe Friesland, Rolf Lewensohn, Simon Ekman

ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases

Download from doi.org

Georgios Tsakonas

, Rolf Lewensohn, Johan Botling, Cristian Ortiz-Villalon, Patrick Micke, Signe Friesland, Helena Nord, Magnus Lindskog, Martin Sandelin, Per Hydbring, Simon Ekman

An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non–small-cell lung cancer

Upload

Georgios Tsakonas

, Vitali Grozman, Simon Ekman

Primary CNS metastatic BRAF mutated lung adenocarcinoma with complete intracranial response to BRAF/MEK inhibition

Upload

R. Califano, F. Gomes, C. J. Ackermann, S. Rafee, G. Tsakonas

, S. Ekman

Immune checkpoint blockade for non–small cell lung cancer: What is the role in the special populations?

Upload

2019 Georgios Tsakonas

, Johan Botling, Patrick Micke

, Chris Rivard

, Linnea LaFleur, Johanna Mattsson, Teresa Boyle, Fred R. Hirsch, Simon Ekman

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer

Upload

2018 Salomon Tendler, Vitali Grozman, Rolf Lewensohn, Georgios Tsakonas

, Kristina Viktorsson, Luigi De Petris

Corrigendum to “Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden” [Lung Cancer 120 (June) (2018) 75–81]

Upload

Salomon Tendler, Vitali Grozman, Rolf Lewensohn, Georgios Tsakonas

, Kristina Viktorsson, Luigi De Petris

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden

Upload

Georgios Tsakonas

, Simon Ekman

Oncogene-addicted non-small cell lung cancer and immunotherapy

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Georgios Tsakonas